NO20054674D0 - Benzotiazolderivatforbindelser, preperater og anvendelser - Google Patents

Benzotiazolderivatforbindelser, preperater og anvendelser

Info

Publication number
NO20054674D0
NO20054674D0 NO20054674A NO20054674A NO20054674D0 NO 20054674 D0 NO20054674 D0 NO 20054674D0 NO 20054674 A NO20054674 A NO 20054674A NO 20054674 A NO20054674 A NO 20054674A NO 20054674 D0 NO20054674 D0 NO 20054674D0
Authority
NO
Norway
Prior art keywords
preparations
applications
derivative compounds
benzothiazole derivative
benzothiazole
Prior art date
Application number
NO20054674A
Other languages
English (en)
Other versions
NO330861B1 (no
NO20054674L (no
Inventor
Jr Chester A Mathis
Yanming Wang
William E Klunk
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/388,173 external-priority patent/US7270800B2/en
Priority claimed from US10/645,847 external-priority patent/US20050043523A1/en
Priority claimed from PCT/US2004/007797 external-priority patent/WO2004083195A1/en
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Publication of NO20054674D0 publication Critical patent/NO20054674D0/no
Publication of NO20054674L publication Critical patent/NO20054674L/no
Publication of NO330861B1 publication Critical patent/NO330861B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
NO20054674A 2003-03-14 2005-10-11 Benzotiazolavledede forbindelser, preparater og anvendelser NO330861B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/388,173 US7270800B2 (en) 2000-08-24 2003-03-14 Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US10/645,847 US20050043523A1 (en) 2003-08-22 2003-08-22 Benzothiazole derivative compounds, compositions and uses
PCT/US2004/007797 WO2004083195A1 (en) 2003-03-14 2004-03-15 Benzothiazole derivative compounds, compositions and uses

Publications (3)

Publication Number Publication Date
NO20054674D0 true NO20054674D0 (no) 2005-10-11
NO20054674L NO20054674L (no) 2005-12-13
NO330861B1 NO330861B1 (no) 2011-08-01

Family

ID=35057877

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20054674A NO330861B1 (no) 2003-03-14 2005-10-11 Benzotiazolavledede forbindelser, preparater og anvendelser
NO20110980A NO20110980L (no) 2003-03-14 2011-07-06 Benzotiazolavledede forbindelser, preparater og anvendelser
NO2015005C NO2015005I1 (no) 2003-03-14 2015-02-18 Flutemetamol (18F)

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO20110980A NO20110980L (no) 2003-03-14 2011-07-06 Benzotiazolavledede forbindelser, preparater og anvendelser
NO2015005C NO2015005I1 (no) 2003-03-14 2015-02-18 Flutemetamol (18F)

Country Status (16)

Country Link
EP (1) EP1611115B1 (no)
JP (1) JP4875487B2 (no)
CN (2) CN102532055B (no)
AU (2) AU2004221897B2 (no)
BE (1) BE2015C005I2 (no)
BR (1) BRPI0408274B8 (no)
CY (2) CY1113334T1 (no)
DK (1) DK1611115T3 (no)
ES (1) ES2393921T3 (no)
HK (1) HK1086270A1 (no)
HU (1) HUS1500006I1 (no)
NO (3) NO330861B1 (no)
PL (1) PL1611115T3 (no)
PT (1) PT1611115E (no)
RU (1) RU2440995C2 (no)
SI (1) SI1611115T1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7270800B2 (en) 2000-08-24 2007-09-18 University Of Pittsburgh Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
HU230375B1 (hu) 2000-08-24 2016-03-29 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Tioflavin-származékok és alkalmazásuk az Alzheimer-kór diagnózisában és kezelésében
WO2005112913A1 (en) * 2004-05-20 2005-12-01 The Scripps Research Institute Transthyretin stabilization
GB0516564D0 (en) * 2005-08-12 2005-09-21 Ge Healthcare Ltd Fluorination process
KR101503940B1 (ko) * 2007-01-30 2015-03-18 지이 헬쓰케어 리미티드 신경퇴행성 질환의 진단을 돕는 수단
CN101293878B (zh) * 2007-04-25 2010-12-15 中国科学院上海应用物理研究所 苯并噻唑苯胺类化合物及其制备方法和应用
KR20110046503A (ko) * 2008-07-24 2011-05-04 지멘스 메디컬 솔루션즈 유에스에이, 인크. Ａｄ 병인을 확인하기에 유용한 영상화제
DK2338059T3 (en) * 2008-09-23 2015-06-15 Wista Lab Ltd Ligands for aggregated tau molecules
KR101770532B1 (ko) 2013-09-26 2017-08-22 에프. 호프만-라 로슈 아게 이미징 수단으로서의 이미다조[1,2-a]피리딘-7-아민
JP6260967B2 (ja) * 2013-11-06 2018-01-17 国立大学法人京都大学 放射性ヨウ素標識化合物、及び、これを含む放射性医薬
CN103613589B (zh) * 2013-11-29 2016-03-30 江苏华益科技有限公司 一种用于神经退行性疾病领域的新型pet显像剂前体及标准品的合成方法
ES2818107T3 (es) * 2014-08-29 2021-04-09 Chdi Foundation Inc Sondas para obtener imágenes de la proteína huntingtina
CN109400615B (zh) * 2017-08-18 2021-07-16 上海交通大学医学院附属新华医院 一种靶向β-淀粉样蛋白的香豆素类化合物及其制备与应用
GR1009516B (el) * 2018-03-22 2019-05-02 Εκεφε Δημοκριτος Τρικαρβονυλο-συμπλοκα μεταλλων μεταπτωσεως με βενζο-ετεροκυκλικο παραγωγο του κυκλοπενταδιενυλικου ανιοντος με υψηλη διαπερατοτητα του αιματοεγκεφαλικου φραγμου για εφαρμογες στη διαγνωση και θεραπεια νοσων του κνς

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0001383A3 (en) * 1996-11-22 2001-11-28 Lilly Co Eli N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same and their use
GB9919673D0 (en) * 1999-08-20 1999-10-20 Cancer Res Campaign Tech 2-Arlybenzazole compounds
HU230375B1 (hu) * 2000-08-24 2016-03-29 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Tioflavin-származékok és alkalmazásuk az Alzheimer-kór diagnózisában és kezelésében
WO2002051821A1 (en) * 2000-12-22 2002-07-04 Astrazeneca Ab Therapeutic compounds
CN100422180C (zh) * 2001-04-23 2008-10-01 宾夕法尼亚州大学理事会 淀粉样斑块聚集抑制剂和诊断成像剂
GB0229686D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase fluorination of benzothiazoles

Also Published As

Publication number Publication date
CN102532055B (zh) 2016-05-11
HUS1500006I1 (hu) 2015-02-18
NO2015005I1 (no) 2015-03-02
JP4875487B2 (ja) 2012-02-15
RU2440995C2 (ru) 2012-01-27
BRPI0408274A (pt) 2006-03-21
RU2005131872A (ru) 2006-02-27
CN1784392A (zh) 2006-06-07
CY2015007I1 (el) 2015-12-09
AU2004221897A9 (en) 2009-08-20
AU2011200667A1 (en) 2011-03-10
PT1611115E (pt) 2012-12-07
NO330861B1 (no) 2011-08-01
NO20110980L (no) 2005-12-13
PL1611115T3 (pl) 2013-01-31
EP1611115B1 (en) 2012-08-22
AU2004221897A2 (en) 2004-09-30
CN102532055A (zh) 2012-07-04
AU2004221897B2 (en) 2010-11-18
BE2015C005I2 (no) 2023-03-07
ES2393921T3 (es) 2013-01-02
EP1611115A1 (en) 2006-01-04
DK1611115T3 (da) 2012-11-26
SI1611115T1 (sl) 2012-12-31
JP2006522104A (ja) 2006-09-28
AU2004221897A1 (en) 2004-09-30
AU2011200667B2 (en) 2011-12-22
NO20054674L (no) 2005-12-13
NO2015005I2 (no) 2015-02-18
BRPI0408274B8 (pt) 2021-05-25
CY1113334T1 (el) 2015-12-09
HK1086270A1 (en) 2006-09-15
BRPI0408274B1 (pt) 2019-02-26

Similar Documents

Publication Publication Date Title
NO20054674D0 (no) Benzotiazolderivatforbindelser, preperater og anvendelser
DK1511734T3 (da) Forbindelser, præparater og fremgangsmåder
NO20053974D0 (no) Tienopyrimidinforbindelser og anvendelse derav.
NO20055568D0 (no) Substituerte 1,4-diazepiner og anvendelser derav
ATE391505T1 (de) Benzothiazole derivative
NL1025404A1 (nl) Pyrazolo-triazine verbindingen en gebruik daarvan.
DK1654360T3 (da) Amplificering fremgangsmåde
ATE340782T1 (de) Piperidinbenzolsulfonamidderivate
ATE478870T1 (de) Spiroindolinpiperidinderivate
ATE460418T1 (de) Heterocyclocarboxamidderivate
ATE450506T1 (de) Indol-3-schwefelderivate
ATE467631T1 (de) Chinuclidinamidderivate
ATE438644T1 (de) Chinazolinderivate
NO20054136D0 (no) Imidazol-4-yl-etynyl-pyridin-derivater
DK1682493T3 (da) Amidoacetonitrilderivater
IS7549A (is) Olíuleysanlegar efnablöndur
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
ATE352550T1 (de) Chinazolinderivate
IS8364A (is) N-þíasól-2-ýl-bensamíð afleiður
NO20054135D0 (no) Kipolinon/benzoksazin derivater og anvendelser derav
DE602004004230D1 (de) Klasse-D Verstärker
DE502004002225D1 (de) Selbstemulgierende Zubereitungen
IS8045A (is) Púrín-6-ón-afleiður
ATE335729T1 (de) 3h-chinazoline -4-on derivaten
ATE423771T1 (de) Tetrahydrochinolinderivate

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: VIZAMYL; REG. NO/DATE: EU/1/14/941 20140822

Spc suppl protection certif: 2015005

Filing date: 20150218

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: VIZAMYL; REG. NO/DATE: EU/1/14/941 20140822; FIRST REG. NO/DATE: EU/1/14/941 20140822;

Spc suppl protection certif: 2015005

Filing date: 20150218

Extension date: 20290315